Optibiotix Health Share Discussion Threads

[rayrac] 13/6/2019 16:02

Glucomannan root fibre. Can you patent anything attaching to that? I doubt it, and it’s in Holland and Barrett!

[riskybusiness1] 13/6/2019 13:20

Patent granted puts Opti in a very strong position.

[primal123] 13/6/2019 12:28

Boombod have definitely infringed it looks like!

[incanus] 13/6/2019 12:25

Does this mean slimfast are about to get a demand for royalties? Happy days.

[parob] 13/6/2019 11:11

Slimbiome tweet: We're thrilled to share that SlimBiome, has had its patent granted in Europe! This provides protection around the use of our invention from production, use, and sales through to importation.

[parob] 13/6/2019 11:10

OPTI just now on twitter:

OptiBiotix's proprietary weight management formulation, @SlimBiome, has had its patent granted in Europe, meaning it is now protected against those who make, use, sell or import it without permission.

[riskybusiness1] 13/6/2019 11:05

Also people completely forget this but the brand & the IP grows in value with every single product on the market. If Opti gave all of its partners LPLDL for pennies (obviously commercial suicide but for examples sake) the value of the brand would increase significantly. I've said this before but it always gets ignored, revenues is not the be all end all in terms of valuations with a biotech growth company like Opti. As mentioned above the branding as well as the IP has significant value alone. Also assets such as SBTX is another valuable asset. Revenues are clearly building & Narbel & Prescott will take the commercialisation up a few notches with their expertise in sales in this very space. It requires patience & I agree with Judi price extremely frustrating.

[riskybusiness1] 13/6/2019 10:54

If people actually read RNS's & listen to what the company say they wouldn't say such silly things. The £25k from Poland isn't the size of the deal it's a single order. 'This agreement has been signed accompanied by an initial modest five figure order and registration of gofigure.pl for online promotion of the products within the Polish market.'They will order a number of times throughout the year clearly growing as they establish their market as with any deal. I believe this is a £250k a year deal which Opti have a number of, 10 of these 'small' deals add up to £2.5m in sales, you then have the medium & larger deals to add on top some such as Alfa Sigma will be £ms per year (not straight out the blocks of course).

[primal123] 13/6/2019 10:29

It's also worth pointing out that LP-LDL is now in Madrid supermarkets, this shows revenues coming in now:SOH:"Through our agreement with IENP, announced on May 7th 2019, LP-LDL is now in in 12 different pharmacies of El Corte Inglés, Spain's biggest department store (a bit like John Lewis). It is being marketed under the 39ytú brand (see below) and present in all 6 of Spain's major Cities (Madrid, Barcelona, Bilbao, Las Palmas, Málaga and Murcia)."Https://www.39ytu.com/articulos/nutricion/ya-puedes-comprar-39ytu-en-la-parafarmacia-de-el-corte-ingles/

[judijudi] 13/6/2019 09:45

The share price is a huge disappointment. Regardless of what anybody says and despite the wild short term price predictions from some of the more ramptastic holders
But patience is a virtue and I have loads
At least we do not have over 6 billion shares in issue (with probably a good chunk more to follow) and a share price struggling to hold just 1p
We have only 80 ish millions shares in issue and we are now covering costs and in profit
The growth can only continue and eventually the share price will follow
Unlike some other companies that spring to mind!!

[reckless kelly] 13/6/2019 09:44

Windy down 'cypress' way it seems.

LOL

[rayrac] 13/6/2019 09:36

Any port in a storm?

[trotterstrading] 13/6/2019 09:11

25k was the UPFRONT order only, more to follow obviously

[incanus] 13/6/2019 09:11

Whitegold, it is interesting you read Elrico's research yet fail to grasp how the business works. The initial £25k will be for promotional inventory for their clients. HLH did something similar. They continually repeat orders. There are 42 agreements. The low volume drip south suggests you are not alone with your thinking. It is really poor research and worse still, bad understanding of the business model which has been discussed at length many times here and on Elrico's blog.

[dire cons] 13/6/2019 08:50

It's a start though. No company with a novel product is going to fill a warehouse before they even know how it will sell?
Hamid, can you and smith get a room please......unless?.....no, surely not?

[whitegold1] 13/6/2019 08:45

I was reading Elrico.s stuff and wondered if anyone baulked at the £25k Poland deal. You.re gonna need approx 40 of said deals to get up to £1m in revenues. We.ll have some naff performers - zap em - and some good performers - Seed ...who will excel. I.m not sure I.d be publishing £25k deals. Just an observation not a criticism. I was surprised.

[rayrac] 13/6/2019 08:12

Even 50p is hard to justify. Very little income, no UK presence other than it’s own online outlet and LPLDL not performing to high enough percentages, ie, 5.1% bp and 13.9% cholesterol.

Too many agreements, not enough contracts visibly bringing cash too the bottom line?

[asterix96] 13/6/2019 08:09

By the time you get a solid ££ forecast, the price will be over £1.

[hamid1970] 13/6/2019 07:55

I really do feel that without a solid ££ forecast we should be no more than 50p.

30+ deals and no figs, come on guys who is hiding what

[judijudi] 12/6/2019 21:43

Master Investor
That’s Bloody Funny. Yet again
:)

[rayrac] 12/6/2019 20:28

Doesn’t make sense to you slartyfartfaster, because like you’ve said before...you’ve only one brain cell.

Oh, and what trades am I making up? You’ve been throwing to many dice...about time you threw a six?

:)